Literature DB >> 22930720

Cytokines and chemokines in the vitreous fluid of eyes with uveal melanoma.

Nisha Nagarkatti-Gude1, Inge H G Bronkhorst, Sjoerd G van Duinen, Gregorius P M Luyten, Martine J Jager.   

Abstract

PURPOSE: In uveal melanoma, both tumor size and an inflammatory phenotype have been shown to correlate with a poor clinical prognosis. The purpose of this study was to identify whether inflammatory cytokines were present in the vitreous of eyes with uveal melanoma and to determine whether the vitreal concentration of cytokines correlated with prognostic variables such as tumor dimensions and immune cell infiltrate.
METHODS: Vitreous was acquired from patients with uveal melanoma (n = 33) and from control eyes with no known ocular conditions (n = 9), and analyzed using a 27-plex cytokine bead array. Immunofluorescence testing was performed to determine the presence of macrophages, CD4(+), CD8(+), and Foxp3(+) regulatory T cells (T(regs)).
RESULTS: Compared with control eyes, eyes with uveal melanoma demonstrated higher vitreal concentrations of many cytokines and chemokines, including IL-6, IL-8, IP-10, MCP-1, MIP-1α, MIP-1β, TNF-α, and RANTES. IL-1ra was decreased in the vitreous of tumor-bearing eyes compared with controls. Tumor prominence positively correlated with several cytokines, including IL-6, IL-8, IP-10, MCP-1, MIP-1α, MIP-1β, TNF-α, RANTES, GCSF, IFN-γ, and VEGF. IL-6 and IP-10 were found to positively correlate with increasing regulatory T-cell infiltrate and IL-6 alone positively correlated with macrophage infiltration.
CONCLUSIONS: Eyes with uveal melanoma contain higher vitreal concentrations of several inflammatory cytokines and chemokines that correlate predominantly with increasing tumor size; elevations in certain cytokines and chemokines also correlate with the presence of immune cell infiltrate.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22930720     DOI: 10.1167/iovs.12-10123

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  26 in total

1.  Cancer Immune Equilibrium and Schizophrenia Have Similar Interferon-γ, Tumor Necrosis Factor-α, and Interleukin Expression: A Tumor Model of Schizophrenia.

Authors:  James S Brown
Journal:  Schizophr Bull       Date:  2016-05-11       Impact factor: 9.306

Review 2.  Ocular diseases: immunological and molecular mechanisms.

Authors:  Jing Song; Yi-Fei Huang; Wen-Jing Zhang; Xiao-Fei Chen; Yu-Mian Guo
Journal:  Int J Ophthalmol       Date:  2016-05-18       Impact factor: 1.779

Review 3.  Immunotherapy for uveal melanoma.

Authors:  Dae Won Kim; Jaime Anderson; Sapna P Patel
Journal:  Melanoma Manag       Date:  2016-05-19

4.  Molecular profiling of primary uveal melanomas with tumor-infiltrating lymphocytes.

Authors:  Pierre L Triozzi; Lynn Schoenfield; Thomas Plesec; Yogen Saunthararajah; Raymond R Tubbs; Arun D Singh
Journal:  Oncoimmunology       Date:  2014-10-31       Impact factor: 8.110

Review 5.  Inflammation in uveal melanoma.

Authors:  I H G Bronkhorst; M J Jager
Journal:  Eye (Lond)       Date:  2012-12-14       Impact factor: 3.775

6.  Cytokine Concentrations in Aqueous Humor of Eyes With Circumscribed Choroidal Hemangioma.

Authors:  Kailin Liu; Lili Guo; Yong Cheng; Jianhong Liang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-28       Impact factor: 6.055

7.  Role of IL-8 induced angiogenesis in uveal melanoma.

Authors:  Laura Lattanzio; Federica Tonissi; Ilaria Torta; Luca Gianello; Elvio Russi; Gerard Milano; Marco Merlano; Cristiana Lo Nigro
Journal:  Invest New Drugs       Date:  2013-08-04       Impact factor: 3.850

8.  Elevated VEGF-A & PLGF concentration in aqueous humor of patients with uveal melanoma following Iodine-125 plaque radiotherapy.

Authors:  Meng-Xi Chen; Yue-Ming Liu; Yang Li; Xuan Yang; Wen-Bin Wei
Journal:  Int J Ophthalmol       Date:  2020-04-18       Impact factor: 1.779

Review 9.  Proteomics in uveal melanoma.

Authors:  Michael J Heiferman; Vinit B Mahajan; Prithvi Mruthyunjaya
Journal:  Curr Opin Ophthalmol       Date:  2022-01-31       Impact factor: 4.299

10.  Breakdown of the blood-eye barrier in choroidal melanoma after proton beam radiotherapy.

Authors:  Annette Hager; Friederike Meissner; Aline-Isabel Riechardt; Theresa Bonaventura; Julia Löwen; Jens Heufelder; Antonia M Joussen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-07-12       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.